Filtered news list test

Filtered news list testing

Vectorio® Registration in India, An Innovative Medical Device for cTACE Procedures

Vectorio® Approved in Canada, An Innovative Medical Device for Interventional Oncology Procedures

Read the article

2019 annual results

Read the article

2019 revenue

Read the article

Lipiodol® Ultra Fluid indicated for hysterosalpingography (HSG) in women undergoing infertility workup in Ireland

Read the article

Vectorio® Registration in Taiwan, An Innovative Medical Device for Interventional Oncology

Read the article

Guerbet receives “B” rating from the CDP for actions taken to prevent global warming

Read the article

Guerbet to present its innovative solution offering for interventional imaging at CIRSE 2019 Barcelona from September 7-11, 2019

Guerbet enriches the visitor experience at Tech Gate during ECR 2019, Vienna

Read the article

Guerbet teams will attend IFFS 2019!

Read the article

Guerbet receives CE mark approval for SeQure® and DraKon™ microcatheters for interventional imaging

Read the article

9
10
11
12
Current page13
14
15
16
17

Single report testing

.pdf

test report fabien V 09-07

Separator

Filtered images

David Hale, CEO Of Guerbet ©Eric LARRAYADIEU

Life At Work At Guerbet HQ ©Eric LARRAYADIEU

Artificial Intelligence And Physician

CT Procedure With Optivantage Multi Use 01

C TACE Procedure With Injection And Emulsion

Guerbet Fill And Finish Site At Aulnay © Patrick Allard REA

Life At Work At Guerbet HQ (2) ©Eric LARRAYADIEU

Guerbet Fill And Finish Site At Aulnay (2) © Patrick Allard REA

Manual news 1

subtitle

item 1 text

item 1 title

Link text

Manual news 2

item 1 text

item 1 title

link

item 2 title

Teest

Discover the latest news of Guerbet

U.S. Food and Drug Administration (FDA) grants Breakthrough Device status to the Guerbet innovation: LIPIOJOINT

Read the press release

2024 revenue

Guerbet, Intrasense, Gustave Roussy and the University Hospital of Angers receive a €5.9M financing from Bpifrance for Liflow^®, innovative solution dedicated to oncology imaging

Read the press release

UNIK: Diagnostic Imaging Interconnected Solutions

UNIK: Diagnostic Imaging Interconnected Solutions

UNIK: Diagnostic Imaging Interconnected Solutions

Interventional Imaging Solutions

Women’s Health

Filtered news list testing

Vectorio® Approved in Canada, An Innovative Medical Device for Interventional Oncology Procedures

2019 annual results

2019 revenue

Lipiodol® Ultra Fluid indicated for hysterosalpingography (HSG) in women undergoing infertility workup in Ireland

Vectorio® Registration in Taiwan, An Innovative Medical Device for Interventional Oncology

Guerbet receives “B” rating from the CDP for actions taken to prevent global warming

Guerbet enriches the visitor experience at Tech Gate during ECR 2019, Vienna

Guerbet teams will attend IFFS 2019!

Guerbet receives CE mark approval for SeQure® and DraKon™ microcatheters for interventional imaging

List of Reports

04/20/2023 - Q1 2023 Revenue

04/19/2023 - Universal Registration Document 2022

03/23/2023 - 2022 Full-year results (Presentation)

03/22/2023 - 2022 annual results

02/09/2023 - 2022 Revenue

01/11/2023 - Intrasense Opens Its Share Capital To The Guerbet Group, Which Announces Its Intent To File A Voluntary Tender Offer Under The Same Price Conditions

01/16/2023 - 2023 Strategic Priorities

11/03/2022 - Guerbet announces a change in governance for its Artificial Intelligence projects

Single report testing

test report fabien V 09-07

Separator

Filtered images

Manual news 1

item 1 title

Manual news 2

item 1 title

item 2 title

Discover the latest news of Guerbet

U.S. Food and Drug Administration (FDA) grants Breakthrough Device status to the Guerbet innovation: LIPIOJOINT

2024 revenue

Guerbet, Intrasense, Gustave Roussy and the University Hospital of Angers receive a €5.9M financing from Bpifrance for Liflow^®, innovative solution dedicated to oncology imaging

UNIK: Diagnostic Imaging Interconnected Solutions

UNIK: Diagnostic Imaging Interconnected Solutions

UNIK: Diagnostic Imaging Interconnected Solutions

Interventional Imaging Solutions

Women’s Health

Filtered news list testing

Vectorio® Approved in Canada, An Innovative Medical Device for Interventional Oncology Procedures

2019 annual results

2019 revenue

Lipiodol® Ultra Fluid indicated for hysterosalpingography (HSG) in women undergoing infertility workup in Ireland

Vectorio® Registration in Taiwan, An Innovative Medical Device for Interventional Oncology

Guerbet receives “B” rating from the CDP for actions taken to prevent global warming

Guerbet enriches the visitor experience at Tech Gate during ECR 2019, Vienna

Guerbet teams will attend IFFS 2019!

Guerbet receives CE mark approval for SeQure® and DraKon™ microcatheters for interventional imaging

List of Reports

04/20/2023 - Q1 2023 Revenue

04/19/2023 - Universal Registration Document 2022

03/23/2023 - 2022 Full-year results (Presentation)

03/22/2023 - 2022 annual results

02/09/2023 - 2022 Revenue

01/11/2023 - Intrasense Opens Its Share Capital To The Guerbet Group, Which Announces Its Intent To File A Voluntary Tender Offer Under The Same Price Conditions

01/16/2023 - 2023 Strategic Priorities

11/03/2022 - Guerbet announces a change in governance for its Artificial Intelligence projects

Single report testing

test report fabien V 09-07

Separator

Filtered images

Manual news 1

item 1 title

Manual news 2

item 1 title

item 2 title

Discover the latest news of Guerbet

U.S. Food and Drug Administration (FDA) grants Breakthrough Device status to the Guerbet innovation: LIPIOJOINT

2024 revenue

Guerbet, Intrasense, Gustave Roussy and the University Hospital of Angers receive a €5.9M financing from Bpifrance for Liflow®, innovative solution dedicated to oncology imaging

Guerbet, Intrasense, Gustave Roussy and the University Hospital of Angers receive a €5.9M financing from Bpifrance for Liflow^®, innovative solution dedicated to oncology imaging